Advertisement

Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte

  • Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte
    Author Footnotes
    1 Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte: Paul E. Rafuse, MD PhD FRCSC (président), Halifax, N.-É; Yvonne M. Buys, MD FRCSC, Toronto, Ont.; Karim F. Damji, MD MBA FRCSC, Edmonton, Alb.; Paul Harasymowycz, MD FRCSC, Montréal, Qc.; Caroline Lajoie, MD, MSc, FRCSC, DABO, Québec, Qc.; Frederick S. Mikelberg MD FRCSC, Vancouver, C.-B; Paul H. Murphy, MD FRCSC, Saskatoon, Sask.; Marcelo Nicolela, MD FRCSC, Halifax, N.-É; David P. Tingey, MD FRCSC, London, Ont.
  • Author Footnotes
    1 Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte: Paul E. Rafuse, MD PhD FRCSC (président), Halifax, N.-É; Yvonne M. Buys, MD FRCSC, Toronto, Ont.; Karim F. Damji, MD MBA FRCSC, Edmonton, Alb.; Paul Harasymowycz, MD FRCSC, Montréal, Qc.; Caroline Lajoie, MD, MSc, FRCSC, DABO, Québec, Qc.; Frederick S. Mikelberg MD FRCSC, Vancouver, C.-B; Paul H. Murphy, MD FRCSC, Saskatoon, Sask.; Marcelo Nicolela, MD FRCSC, Halifax, N.-É; David P. Tingey, MD FRCSC, London, Ont.
      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      Références

        • Davis D
        • Golman J
        • Palda VA
        Handbook on Clinical Practice Guidelines. Canadian Medical Association, Ottawa, ON2007
        • Jacobsen PD
        Transforming clinical practice guidelines into legislative mandates. Proceed with abundant caution.
        JAMA. 2007; 299: 208-210
        • Canadian Diabetes Association Clinical Practice Guideline Expert Committee
        Canadian Diabetes Association Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
        Can J Diabetes. 2008; 32: S1-S201
        • Canadian Hypertension Education Program
        2008 CHEP Recommendations for the Management of Hypertension.
        (Available at:) (Accessed March 23, 2009)
        • AGREE Collaboration
        Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. 2001; (Available at:) (Accessed March 15, 2009)
        • Gordon MA
        • Beiser JA
        • Brandt JD
        • et al.
        The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120: 714-720
        • Leske MC
        • Wu SY
        • Hennis A
        • Honaknen R
        • Nemesure B
        • BESs Study Group
        Risk factors for incident openangle glaucoma: the Barbados Eye Studies.
        Ophthalmology. 2008; 115: 85-93
        • Dielemans I
        • Vingerling JR
        • Wolfs RC
        • et al.
        The prevalence of open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study.
        Ophthalmol. 1994; 101: 1851-1855
        • Sommer A
        • Tielsch JM
        • Katz J
        • et al.
        Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.
        Arch Ophthalmol. 1991; 109: 1090-1095
        • Mitchell P
        • Smith W
        • Attebo K
        • Healey PR
        Prevalence of open-angle glaucoma in Australia—The Blue Mountains Eye Study.
        Ophthalmology. 1996; 103: 1661-1669
        • AGIS Investigators
        The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.
        Am J Ophthalmol. 2000; 130: 429-440
        • Collaborative Normal-Tension Glaucoma Study Group
        Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures.
        Am J Ophthalmol. 1998; 126: 487-497
        • Leske MC
        • Heijl A
        • Hussein M
        • Bengtsson B
        • Hyman L
        • Komaroff E
        • Early Manifest Glaucoma Trial Group
        Factors for glaucoma progression and the effect of treatment.
        Arch Ophthalmol. 2003; 121: 48-56
      1. Congenital glaucomas.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shield’s Textbook of Glaucoma. 5th ed. Lippincott Williams & Wilkins, Baltimore, Md.2005: 235-251
      2. Morrison JC Pollack IP Glaucoma: Science and Practice. Thieme, New York, N.Y.2003
      3. Stamper RL Lieberman MF Drake MV Becker-Shaffer’s: Diagnosis and Therapy of the Glaucomas. 7th ed. Mosby, St. Louis, Mo.1999
        • Walton DS
        • Katsavounido G
        Newborn primary congenital glaucoma: 2005 update.
        J Pediatr Ophthalmol Strabismus. 2005; 42: 333-341
        • Greenfield DS
        Glaucoma associated with elevated episcleral venous pressure.
        J Glaucoma. 2000; 9: 190-194
        • Alwards WLM
        Gonioscopy.org. A Video Atlas.
        (Available at:) (Accessed December 16, 2008.)
        • Iwase A
        • Suzuki Y
        • Araie M
        • et al.
        • Tajimi Study Group, Japan Glaucoma Society
        The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.
        Ophthalmology. 2004; 111: 1641-1648
        • Lee BL
        • Gutierrez P
        • Gordon M
        • et al.
        The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms.
        Arch Ophthalmol. 1998; 116: 861-866
        • Quigley HA
        • Friedman DS
        • Congdon NG
        Possible mechanisms of primary angle closure and malignant glaucoma.
        J Glaucoma. 2003; 12: 167-180
        • Mandell MA
        • Pavlin CJ
        • Weisbrod DJ
        • Simpson ER
        Anterior chamber depth in plateau iris syndrom and pupillary block as measured by ultrasound biomicroscopy.
        Am J Ophthalmol. 2003; 136: 900-903
        • Pavlin CJ
        • Ritch R
        • Foster FS
        Ultrasound biomicroscopy in plateau iris syndrome.
        Am J Ophthalmol. 1992; 113: 390-395
        • Ritch R
        • Schlotzer-Schrehardt U
        Exfoliation syndrome.
        Surv Ophthalmol. 2001; 45: 265-315
        • Wishart PK
        • Spaeth GL
        • Poryzees EM
        Anterior chamber angle in the pseudoexfoliation syndrome.
        Br J Ophthalmol. 1985; 69: 103-107
        • Gross FJ
        • Tingey D
        • Epstein DL
        Increased prevalence of oc-cludable angles and angle-closure glaucoma in patients with pseudoexfoliation.
        Am J Ophthalmol. 1994; 117: 333-336
        • Speakman JS
        Pigmentary dispersion.
        Br J Ophthalmol. 1981; 65: 249-251
        • Ritch R
        Pigment dispersion syndrome.
        Am J Ophthalmol. 1998; 126: 442-445
        • Kaufman JH
        • Tolpin DW
        Glaucoma after traumatic angle recession: a ten year prospective study.
        Am J Ophthalmol. 1974; 79: 648-654
        • Vasconcelos-Santos DV
        • Nehemy PG
        • Schachat AP
        • Nehemy MB
        Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
        Retina. 2008; 28: 573-580
        • Hayreh SS
        Neovascular glaucoma.
        Prog Retin Eye Res. 2007; 26: 470-485
      4. Classification of the glaucomas.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shield’s Textbook of Glaucoma. 5th ed. Lippincott Williams & Wil-kins, Baltimore, Md.2005: 155-162
        • Hyams SW
        • Keroub C
        • Pokotilo E
        Mixed glaucoma.
        Br J Oph-thalmol. 1977; 61: 105-106
        • Resnikoff S
        • Pascolini D
        • Etaya’ale D
        • et al.
        Global data on visual impairment in the year 2002.
        Bull WHO. 2004; 82: 844-851
        • Foster PJ
        • Johnson GJ
        Glaucoma in China: how big is the problem?.
        Br J Ophthalmol. 2001; 85: 1277-1282
        • Quigley HA
        • Broman AT
        The number of people with glaucoma worldwide in 2010 and 2020.
        Br J Ophthalmol. 2006; 90: 262-267
        • Leske MC
        Open-angle glaucoma: An epidemiologic review.
        Ophthalmic Epidemiol. 2007; 14: 166-172
        • Friedman DS
        • Wolfs RC
        • O’Colmain BJ
        • et al.
        • Eye Diseases Prevalence Research Group
        Prevalence of open-angle glaucoma among adults in the United States.
        Arch Ophthalmol. 2004; 122: 532-538
        • Quigley HA
        • West SK
        • Rodrigues J
        • Muñoz B
        • Klein R
        • Sny-der R
        The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.
        Arch Ophthalmol. 2001; 119: 1819-1826
        • Perruccio AV
        • Badley EM
        • Trope GE
        Self-reported glaucoma in Canada: findings from population-based surveys, 1994-2003.
        Can J Ophthalmol. 2007; 42: 219-226
        • Maberley DAL
        • Holland H
        • Chuo J
        • et al.
        The prevalence of low vision and blindness in Canada.
        Eye. 2006; 20: 341-346
        • Hirsch JD
        • Morello C
        • Singh R
        • et al.
        Pharmacoeconomics of new medications for common chronic ophthalmic diseases.
        Surv Ophthalmol. 2007; 52: 618-633
      5. Wilson JMG Jungner G Principes et Pratique du Dépistage des Maladies. World Health Organization, Geneva, Switzerland1970 (Cahiers de Santé Publique No 34. ISBN: 92 4 2300349. Available at:) (Accessed November 8, 2004)
        • Patterson C
        Screening for visual impairment in the elderly.
        in: Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Health Canada, Ottawa, On.1994: 932-942 (Cat. H21-117/1994E. Available at:) (Accessed March 1, 2009.)
        • Einarson TR
        • Vicente C
        • Machado M
        • Covert D
        • Trope GE
        • Iskedjian M
        Screening for glaucoma in Canada: a systematic review of the literature.
        Can J Ophthalmol. 2006; 41: 709-721
        • Kass MA
        • Heuer DK
        • Higginbotham EJ
        • et al.
        The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120: 701-713
        • Heijl A
        • Leske MC
        • Bengtsson B
        • et al.
        • Early Manifest Glaucoma Trial Group
        Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
        Arch Ophthalmol. 2002; 120: 1268-1279
        • Chauhan BC
        • Mikelberg FS
        • Balaszi AG
        • LeBlanc RP
        • Lesk MR
        • Trope GE
        • Canadian Glaucoma Study Group
        Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma.
        Arch Ophthalmol. 2008; 126: 1030-1036
        • Burr JM
        • Mowatt G
        • Hernandez R
        • et al.
        The clinical effectiveness and cost-effectiveness of screening for open-angle glaucoma: a systematic review and economic evaluation.
        Health Technol Assess. 2007; 11: 1-190
        • Côté B
        • Rodriguez N
        Dépistagepopulationnelduglaucomeprimi-tif à angle ouvert. Agence d’évaluation des technologies et des modes d’intervention en santé, Montreal, QC2007 (Available at:) (Accessed August 3, 2008)
        • Canadian Task Force on the Periodic Health Examination
        Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients.
        CMAJ. 1995; 152: 1211-1222
        • Harasymowycz P
        • Kamdeu Fansi A
        • Papamatheakis D
        Screening for primary open-angle glaucoma in the developed world: are we there yet?.
        Can J Ophthalmol. 2005; 40: 477-486
        • Harasymowycz P
        • Papamatheakis D
        • Fansi AK
        • Gresset J
        • Lesk MR
        Validity of screening for glaucomatous optic nerve damage using confocal scanning laser Ophthalmoscopy (Heidelberg Retina Tomograph II) in high-risk populations: a pilot study.
        Ophthalmology. 2005; 112: 2164-2171
      6. Weinreb RN Healy PR Topouzis F World Glaucoma Association Consensus. Glaucoma Screening. Consensus Series 5. Kugler Publications, Amsterdam, The Netherlands2008
        • Tuck MW
        • Crick RP
        The age distribution of primary open angle glaucoma.
        Ophthalmic Epidemiol. 1998; 5: 173-183
        • Rezaie T
        • Child A
        • Hitchings R
        • et al.
        Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
        Science. 2002; 295: 1077-1079
        • Kerrigan-Baumrind LA
        • Quigley HA
        • Pease ME
        • Kerrigan DF
        • Mitchell RS
        Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.
        Invest Ophthalmol Vis Sci. 2000; 41: 741-748
        • Quaranta GM
        • Vetrugno M
        • Trabucco T
        • Cantatore F
        • Cardia L
        The role of frequency doubling technology (FDT) in glaucoma screening.
        Acta Ophthalmol Scand Suppl. 2000; 232: 21-23
        • Medeiros FA
        • Sample PA
        • Weinreb RN
        Frequency doubling technology perimetry abnormalities as predictors of glaucoma-tous visual field loss.
        Am J Ophthalmol. 2004; 137: 863-871
        • Quigley HA
        • Dunkelberger GR
        • Green WR
        Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.
        Ophthalmology. 1988; 95: 357-363
        • Yamada N
        • Chen PP
        • Mills RP
        • et al.
        Screening for glaucoma with frequency-doubling technology and Damato campimetry.
        Arch Ophthalmol. 1999; 117: 1479-1484
        • Trible JR
        • Schultz RO
        • Robinson JC
        • Rothe TL
        Accuracy of glaucoma detection with frequency-doubling perimetry.
        Am J Ophthalmol. 2000; 129: 740-745
        • Thomas R
        • Bhat S
        • Muliyil JP
        • Parikh R
        • George R
        Frequency doubling perimetry in glaucoma.
        J Glaucoma. 2002; 11: 46-50
        • Tatemichi M
        • Nakano T
        • Tanaka K
        • et al.
        Laterality of the performance of glaucoma mass screening using frequency-doubling technology.
        J Glaucoma. 2003; 12: 221-225
        • Soliman MA
        • de Jong LA
        • Ismaeil AA
        • van den Berg TJ
        • de Smet MD
        Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage.
        Ophthalmology. 2002; 109: 444-454
        • Maeda H
        • Tanaka Y
        • Nakamura M
        • Yamamoto M
        Blue-on-yellow perimetry using an Armaly glaucoma screening program.
        Ophthalmologica. 1999; 213: 71-75
        • Chia WL
        • Goldberg I
        • Bauman A
        oculokinetic perimetry chart be improved?.
        Aust NZJ Ophthalmol. 1999; 27: 312-317
        • Chia WL
        • Goldberg I
        • Bauman A
        Evaluation of oculokinetic perimetry.
        Aust NZJ Ophthalmol. 1999; 27: 306-311
        • Sponsel WE
        • Arango S
        • Trigo Y
        • Mensah J
        Clinical classification of glaucomatous visual field loss by frequency doubling perimetry.
        Am J Ophthalmol. 1998; 125: 830-836
        • Christoffersen T
        • Fors T
        • Waage S
        • Holtedahl K
        Glaucoma screening with oculokinetic perimetry in general practice: is its specificity acceptable?.
        Eye. 1995; 9: 36-39
        • Wang F
        • Quigley HA
        • Tielsch JM
        Screening for glaucoma in a medical clinic with photographs of the nerve fiber layer.
        Arch Ophthalmol. 1994; 112: 796-800
        • Bowd C
        • Zangwill LM
        • Berry C
        • et al.
        Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function.
        Invest Ophthalmol Vis Sci. 2001; 42: 1993-2003
        • Ntim-Amponsah CT
        Intraocular pressure asymmetry—Topcon Computerized Tonometer CT-20.
        West Afr J Med. 1997; 16: 191-194
        • Swindale NV
        • Stjepanovic G
        • Chin A
        • Mikelberg F
        Automated analysis of normal and glaucomatous optic nerve head topography images.
        Invest Ophthalmol Vis Sci. 2000; 41: 1730-1742
        • Tuulonen A
        • Ohinmaa A
        • Alanko HI
        • Hyytinen P
        • Juutinen A
        • Toppinen E
        The application of teleophthalmology in examining patients with glaucoma: a pilot study.
        J Glaucoma. 1999; 8: 367-373
        • Li HK
        • Tang RA
        • Oschner K
        • Koplos C
        • Grady J
        • Crump WJ
        Telemedicine screening of glaucoma.
        Telemed J. 1999; 5: 283-290
        • Yogesan K
        • Constable IJ
        • Eikelboom RH
        • van Saarloos PP
        Teleophthalmic screening using digital imaging devices.
        Aust NZJ Ophthalmol. 1998; 26: S9-11
        • Taylor JR
        • Pezzullo ML
        • Keeffe JE
        The economic impact and cost of visual impairment in Australia.
        Br J Ophthalmol. 2006; 90: 272-275
        • Schmier JK
        • Halpem MT
        • Jones ML
        The economic implications of glaucoma: a literature review.
        Pharmacoeconomics. 2007; 25: 287-308
        • Rein DB
        • Zhang P
        • Wirthe KE
        • et al.
        The economic burden of major adult visual disorders in the United States.
        Arch Ophthalmol. 2006; 124: 1754-1760
        • Frick KD
        • Gower EW
        • Kempen JH
        • Wolff JL
        Economic impact of visual impairment and blindness in the United States.
        Arch Ophthalmol. 2007; 125: 544-550
        • Kobelt-Nguyen G
        • Gerdtham UG
        • Alm A
        Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observation two-year chart review of newly diagnosed patients in Sweden and the United States.
        J Glaucoma. 1998; 7: 95-104
        • Traverso CE
        • Walt JG
        • Kelly SP
        • et al.
        Direct costs of glaucoma and severity of the disease; a multinational long term study of resource utilization in Europe.
        Br J Ophthalmol. 2005; 89: 1245-1249
        • Lee PP
        • Walt JG
        • Doyle JJ
        • et al.
        A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
        Arch Ophtahlmol. 2006; 124: 12-19
        • Lee PP
        • Kelly SP
        • Mills RP
        • et al.
        • Costs of Glaucoma Study Group
        Glaucoma in the United States and Europe: predicting costs and surgical rates based upon stage of disease.
        J Glaucoma. 2007; 16: 471-478
        • Lee PP
        • Levin LA
        • Walt JG
        • et al.
        Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data.
        Ophthalmology. 2007; 114: 1241-1247
        • Kymes SM
        • Kass MA
        • Anderson DR
        • Miller JP
        • Gordon MO
        • Ocular Hypertension Treatment Study Group
        Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
        Am J Ophthalmol. 2006; 141: 997-1008
        • Stewart WC
        • Stewart JA
        • Nassar QJ
        • Mychaskiw MA
        Costeffectiveness of treating ocular hypertension.
        Ophthalmology. 2008; 115: 94-98
        • Thygesen J
        • Aagren M
        • Amavielle S
        • et al.
        Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries.
        Curr Med Res Opin. 2008; 24: 1763-1770
        • Iskedjian M
        • Walker J
        • Vicente C
        • Trope GE
        • Buys Y
        • Einarson TR
        • Covert D
        Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.
        J Glaucoma. 2003; 12: 456-462
        • Canadian Ophthalmological Society Clinical Practice Guideline Expert Committee
        Canadian Ophthalmological Society evidence-based clinical practice guidelines for the periodic eye examination in adults in Canada.
        Can J Ophthalmol. 2007; 42: 39-45
        • Greenfield DS
        • Siatkowski RM
        • Glaser JS
        • Schatz NJ
        • Parrish 2nd, RK
        The cupped disc. Who needs neuroimaging?.
        Ophthalmology. 1998; 105: 1866-1874
        • Le A
        • Mukesh BN
        • McCarty CA
        • Taylor R
        Risk factors associated with incidence of open-angle glaucoma: the visual impairment project.
        Invest Ophthalmol Vis Sci. 2003; 44: 3783-3789
        • Nemesure B
        • Leske MC
        • He Q
        • Mendell N
        Analysis of reported family history of glaucoma: a preliminary investigation. The Barbados Eye Study Group.
        Ophthalmic Epidemiol. 1996; 3: 135-141
        • Wolfs RC
        • Klaver CC
        • Ramrattan RS
        • van Duijn CM
        • Hofman A
        • de Jong PT
        v. Population-based familial aggregation study.
        Arch Ophthalmol. 1998; 116: 1640-1645
        • Kaimbo DK
        • Buntinx F
        • Missotten L
        Risk factors for open-angle glaucoma: a case-control study.
        J Clin Epidemiol. 2001; 54: 166-171
        • Tielsch JM
        • Katz J
        • Sommer A
        • Quigley HA
        • Javitt JC
        • et al.
        Family history and the risk of primary open angle glaucoma. The Baltimore Eye Survey.
        Arch Ophthalmol. 1994; 112: 69-73
        • Nemesure B
        • He Q
        • Mendell N
        • et al.
        • Barbados Family Study Group
        Inheritance of open-angle glaucoma in the Barbados family study.
        Am J Med Genet. 2001; 103: 36-43
        • Nguyen RL
        • Raja SC
        • Traboulsi EI
        Screening relatives of patients with familial chronic open angle glaucoma.
        Ophthalmology. 2000; 107: 1294-1297
        • Wickham L
        • Edmunds B
        • Murdoch IE
        Can the current oculokinetic perimetry chart be improved?.
        Ophthalmology. 2005; 112: 225-228
        • Dueker DK
        • Singh K
        • Lin SC
        • et al.
        Corneal thickness measurement in the management of primary open angle glaucoma. A report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1779-1787
        • Hoskins Jr, HD
        • Kass MA
        Gonioscopy.
        in: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 6th ed. Mosby, St. Louis, Mo.1989: 106-116
      7. Tasman W Jaeger EA Duane's Clinical Ophthalmology. JB Lippincott Co, Philadelphia, Pa2004
        • Kirwan JF
        • Gouws P
        • Linnell AE
        • Crowston J
        • Bunce C
        Pharmacological mydriasis and optic disc examination.
        Br J Ophthalmol. 2000; 84: 894-898
        • Ariyasu RG
        • Lee PP
        • Linton KP
        • LaBree LD
        • Azen SP
        • Siu AL
        Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population.
        Ophthalmology. 1996; 103: 1751-1760
        • Batchelder TJ
        • Fireman B
        • Friedman GD
        • et al.
        The value of routine dilated pupil screening examination.
        Arch Ophthalmol. 1997; 115: 1179-1184
        • Ferraro JG
        • Mazzoni LL
        • Keeffe JE
        • Vu HT
        • Constantinou M
        • Taylor HR
        Evaluation of an eye health program: the vision initiative.
        Ophthalmic Epidemiol. 2006; 13: 127-135
        • Taylor HR
        • Vu HT
        • McCarty CA
        • Keeffe JE
        The need for routine eye examinations.
        Invest Ophthalmol Vis Sci. 2004; 45: 2539-2542
        • Leske MC
        • Wu SY
        • Nemesure B
        • Hennis A
        Incident open-angle glaucoma and blood pressure.
        Arch Ophthalmol. 2002; 120: 954-959
        • Jonas JB
        • Gusek GC
        • Naumann GO
        Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes.
        Invest Ophthalmol Vis Sci. 1988; 29: 1151-1158
        • Jonas JB
        • Gusek GC
        • Naumann GO
        Optic disc morphom-etry in chronic primary open-angle glaucoma, I: morphometric intrapapillary characteristics.
        Graefes Arch Clin Exp Ophthalmol. 1988; 226: 522-530
        • Harizman N
        • Oliveira C
        • Chiang A
        • et al.
        The ISNT rule and differentiation of normal from glaucomatous eyes.
        Arch Ophthalmol. 2006; 124: 1579-1583
        • Quigley HA
        • Varma R
        • Tielsch JM
        • Katz J
        • Sommer A
        • Gilbert DL
        The relationship between optic disc area and open-angle glaucoma: the Baltimore Eye Survey.
        J Glaucoma. 1999; 8: 347-352
        • Healey PR
        • Mitchell P
        Optic disc size in open-angle glaucoma: the Blue Mountains Eye Study.
        Am J Ophthalmol. 1999; 128: 515-517
        • Jonas JB
        • Budde WM
        • Lang PJ
        Parapapillary atrophy is associated with chronic open-angle glaucomas.
        Graefes Arch Clin Exp Ophthalmol. 1999; 237: 793-799
        • Park KH
        • Tomita G
        • Liou SY
        • Kitazawa Y
        Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma.
        Ophthalmology. 1996; 103: 1899-1906
        • Diehl DL
        • Quigley HA
        • Miller NR
        • Sommer A
        • Burney EN
        Prevalence and significance of optic disc hemorrhage in a longitudinal study of glaucoma.
        Arch Ophthalmol. 1990; 108: 545-550
        • Healey PR
        • Mitchell P
        • Smith W
        • Wang JJ
        Optic disc hemorrhages in a population with and without signs of glaucoma.
        Ophthalmology. 1998; 105: 216-223
        • Mitchell P
        • Wang JJ
        • Hourihan F
        The relationship between glaucoma and pseudoexfoliation. The Blue Mountains Eye Study.
        Arch Ophthalmol. 1999; 117: 1319-1324
        • Foster PJ
        • Machin D
        • Wong TY
        • et al.
        Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study.
        Invest Ophthalmol Vis Sci. 2003; 44: 3885-3891
        • Nemesure B
        • Wu SY
        • Hennis A
        • Leske MC
        • Barbados Eye Study Group
        Corneal thickness and intraocular pressure in the Barbados Eye Studies.
        Arch Ophthalmol. 2003; 121: 240-244
        • Vijaya L
        • George R
        • Paul PG
        • et al.
        Prevalence of open-angle glaucoma in a rural south Indian population.
        Invest Ophthalmol Vis Sci. 2005; 46: 4461-4467
        • Siddiqui Y
        • Ten Hulzen RD
        • Cameron JD
        • Hodge DO
        • Johnson DH
        What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome?.
        Am J Ophthalmol. 2003; 135: 794-799
        • Mitchell P
        • Hourihan F
        • Sandbach J
        • Wang JJ
        The relationship between glaucoma and myopia: the Blue Mountains Eye Study.
        Ophthalmology. 1999; 106: 2010-2015
        • Ramakrishnan R
        • Nirmalan PK
        • Krishnadas R
        • et al.
        Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
        Ophthalmology. 2003; 110: 1484-1490
        • Martinez GC
        • Campbell AJ
        • Reinken J
        • Allan BC
        Prevalence of ocular disease in a population study of subjects 65 years old and older.
        Am J Ophthalmol. 1982; 91: 181-189
        • Leske MC
        • Connell AM
        • Wu SY
        • et al.
        Risk factors for open-angle glaucoma: the Barbados Eye Study.
        Arch Ophthalmol. 1995; 113: 918-924
        • Mukesh BN
        • McCarty CA
        • Rait JL
        • Taylor HR
        Five-year incidence of open-angle glaucoma: the visual impairment project.
        Ophthalmology. 2002; 109: 1047-1051
        • Tielsch JM
        • Sommer A
        • Katz J
        • Royall RM
        • Quigley HA
        • Javitt J
        Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.
        JAMA. 1991; 266: 369-374
        • Leske MC
        • Connell AM
        • Schachat AP
        • et al.
        • The Barbados Eye Study
        Prevalence of open angle glaucoma.
        Arch Ophthalmol. 1994; 112: 821-829
        • Friedman DS
        • Jampel HD
        • Munõz B
        • West SK
        The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Study.
        Arch Ophthalmol. 2006; 121: 1625-1630
        • Stone EM
        • Fingert JH
        • Alward WL
        • et al.
        Identification of a gene that causes primary open angle glaucoma.
        Science. 1997; 275: 668-670
        • Aung T
        • Ocaka L
        • Ebenezer ND
        • et al.
        A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene.
        Hum Genet. 2002; 110: 52-62
        • Copin B
        • Brézin AP
        • Valtot F
        • Dascotte JC
        • Béchetoille A
        • Garchon HJ
        Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.
        Am J Hum Genet. 2002; 70: 1575-1581
        • Vickers JC
        • Craig JE
        • Stankovich J
        • et al.
        The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma.
        Mol Vis. 2002; 8: 389-393
        • Phelps CD
        • Corbett JJ
        Migraine and low-tension glaucoma. A case-control study.
        Invest Ophthalmol Vis Sci. 1985; 26: 1105-1108
        • Wang JJ
        • Mitchell P
        • Smith W
        Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountain Eye Study.
        Ophthalmology. 1997; 104: 1714-1719
        • Drance S
        • Anderson DR
        • Schulzer M
        • Collaborative Normal-Tension Glaucoma Study Group
        Risk factors for progression of visual field abnormalities in normal-tension glaucoma.
        Am J Ophthalmol. 2001; 131: 699-708
        • Garbe E
        • LeLorier J
        • Boivin JF
        • Suissa S
        Risk of ocular hypertension or open angle glaucoma in elderly patients on oral glucocorticoids.
        Lancet. 1997; 350: 979-982
        • Mitchell P
        • Cumming RG
        • Mackey DA
        Inhaled corticoster-oids, family history, and risk of glaucoma.
        Ophthalmology. 1999; 106: 2301-2306
        • Quigley HA
        • Enger C
        • Katz J
        • Sommer A
        • Scott R
        • Gilbert D
        Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
        Arch Ophthalmol. 1994; 112: 619-644
        • Landers J
        • Goldberg I
        • Graham SL
        Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma.
        Clin Experiment Ophthalmol. 2002; 30: 242-247
        • Thomas R
        • Parikh R
        • George R
        • Kumar RS
        • Muliyil J
        Five-year risk of progression of ocular hypertension to primary open angle glaucoma. A population-based study.
        Indian J Ophthal-mol. 2003; 51: 329-333
        • Zangwill LM
        • Weinreb RN
        • Beiser JA
        • et al.
        Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
        Arch Ophthalmol. 2005; 123: 1188-1197
        • Budenz DL
        • Anderson DR
        • Feuer WJ
        • et al.
        Ocular hypertension treatment study group. Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study.
        Ophthalmology. 2006; 113: 2137-2143
        • Perkins ES
        • Phelps CD
        Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction.
        Arch Ophthalmol. 1982; 100: 1464-1467
        • Weinreb RN
        • Friedman DS
        • Fechtner RD
        • et al.
        Risk assessment in the management of patients with ocular hypertension.
        Am J Ophthalmol. 2004; 138: 458-467
        • Bill A
        Some aspects of aqueous humour drainage.
        Eye. 1993; 7: 14-19
        • Kitazawa Y
        • Horie T
        Diurnal variation of intraocular pressure in primary open-angle glaucoma.
        Am J Ophthalmol. 1975; 79: 557-566
        • Newell FW
        • Krill AE
        Diurnal tonography in normal and glau-comatous eyes.
        Trans Am Ophthalmol Soc. 1964; 62: 349-374
        • Whitacre MM
        • Stein R
        Sources of error with use of Goldmanntype tonometers.
        Surv Ophthalmol. 1993; 38: 1-30
      8. Intraocular pressure and tonometry.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shields' Textbook of Glaucoma. 5th ed. Lippincott Williams & Wilkins, Baltimore, Md.2005: 36-58
        • Damji KF
        • Muni RH
        • Munger RM
        Influence of corneal variables on accuracy of intraocular pressure measurement.
        J Glaucoma. 2003; 12: 69-80
        • South East Asia Glaucoma Interest Group
        Asia Pacific Glaucoma Guidelines. 2nd ed. Scientific Communications, Hong Kong2008: 1-117
        • Shields MB
        The non-contact tonometer. Its value and limitations.
        Surv Ophthalmol. 1980; 24: 211-219
        • Faucher A
        • Grégoire J
        • Blondeau P
        Accuracy of Goldmann tonometry after refractive surgery.
        J Cataract Refract Surg. 1997; 23: 832-838
        • Phelps CD
        • Phelps GK
        Measurement of intraocular pressure: a study of its reproducibility.
        Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976; 198: 39-43
        • Whitacre MM
        • Stein RA
        • Hassanein K
        The effect of cor- neal thickness on applanation tonometry.
        Am J Ophthalmol. 1993; 115: 592-599
        • Damji KF
        • Behki R
        • Wang L
        • et al.
        Canadian perspectives in glaucoma management: setting target intraocular pressure range.
        Can J Ophthalmol. 2003; 38: 189-197
        • Behki R
        • Damji KF
        • Crichton A
        • CCT workshop participants
        Canadian perspectives in glaucoma management: the role of central corneal thickness.
        Can J Ophthalmol. 2007; 42: 66-74
        • Brandt JD
        Central corneal thickness, tonometry, and glaucoma risk-a guide for the perplexed.
        Can J Ophthalmol. 2007; 42: 562-566
        • Miglior S
        • Pfeiffer N
        • Torri V
        • Zeyen T
        • Cunha-Vaz J
        • Adamsons I
        • European Glaucoma Prevention Study (EGPS) Group
        Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
        Ophthalmology. 2007; 114: 3-9
        • Brandt JD
        • Beiser JA
        • Gordon MO
        • Kass MA
        • Ocular Hypertension Treatment Study Group
        Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
        Am J Ophthalmol. 2004; 138: 717-722
        • Aakre BM
        • Doughty MJ
        • Dalane OV
        • Berg A
        • Aamodt O
        • Gangstad H
        Assessment of reproducibility of measures of intraocular pressure and central corneal thickness in young white adults over a 16-h time period.
        Ophthalmic Physiol Opt. 2003; 23: 271-283
        • McMillan F
        • Forester RK
        Comparison of the MacKay-Marg, Goldmann and Perkins tonometers in abnormal corneas.
        Arch Ophthalmol. 1975; 93: 420-424
        • Stelzer R
        Die beziehunger des innendruckes zur auberen applanation der hornhaut enucleierter augen.
        Graefes Arch Klin Ophthalmol. 1974; 189: 33-41
        • Moses RA
        The Goldmann applanation tonometer.
        Am J Ophthalmol. 1958; 46: 865-869
        • Simon G
        • Small RH
        • Ren Q
        • Parel J-M
        Effect of corneal hydration on Goldmann applanation tonometry and corneal topography.
        Refract Corneal Surg. 1993; 9: 110-117
        • Kaufman HE
        Pressure measurement: Which tonometer?.
        Invest Ophthal. 1972; 11: 80-85
        • Bathija R
        • Zangwill L
        • Berry CC
        • Sample PA
        • Weinreb RN
        Detection of early glaucomatous structural damage with confocal scanning laser tomography.
        J Glaucoma. 1998; 7: 121-127
        • Bowd C
        • Chan K
        • Zangwill LM
        • et al.
        Comparing neural networks and linear discriminant functions for glaucoma detection using confocal scanning laser ophthalmoscopy of the optic disc.
        Invest Ophthalmol Vis Sci. 2002; 43: 3444-3454
        • Iester M
        • Mardin CY
        • Budde WM
        • Jünemann AG
        • Hayler JK
        • Jonas JB
        Discriminant analysis formulas of optic nerve head parameters measured by confocal scanning laser tomography.
        J Glaucoma. 2002; 11: 97-104
        • Zangwill LM
        • Weinreb RN
        • Berry CC
        • et al.
        Racial differences in optic disc topography: baseline results from the Con-focal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
        Arch Ophthalmol. 2004; 122: 22-28
        • Nicolela MT
        • Soares AS
        • Carillo MM
        • Chauhan BC
        • LeBlanc RP
        • Artes PH
        Effect of moderate intraocular pressure changes on topographic measurements with confocal scanning laser tomography in patients with glaucoma.
        Arch Ophthalmol. 2006; 124: 633-640
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Vasile C
        • Sample PA
        • Weinreb RA
        Agreement between stereophotographic and con-focal scanning laser ophthalmoscopy measurements of cup/disc ratio: effect on a predictive model for glaucoma development.
        J Glaucoma. 2007; 16: 209-214
        • Wollstein G
        • Schuman JS
        • Price LL
        • et al.
        Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields.
        Am J Ophthalmol. 2004; 138: 218-225
        • Budenz DL
        • Chang RT
        • Huang X
        • Knighton RW
        • Tielsch JM
        Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes.
        Invest Ophthalmol Vis Sci. 2005; 46: 2440-2443
        • Leung CK
        • Chong KK
        • Chan WM
        • et al.
        Comparative study of retinal nerve fiber layer measurement by Stratus OCT and GDx VCC, II: structure/function regression analysis in glaucoma.
        Invest Ophthalmol Vis Sci. 2005; 46: 3702-3711
        • Arthur SN
        • Aldridge AJ
        • De León-Ortega J
        • McGwin G
        • Xie A
        • Girkin CA
        Agreement in assessing cup-to-disc ratio measurement among stereoscopic optic nerve head photographs, HRT II, and Stratus OCT.
        J Glaucoma. 2006; 15: 183-189
        • Parikh RS
        • Parikh S
        • Sekhar GC
        • et al.
        Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma.
        Ophthalmology. 2007; 114: 2238-2243
        • Weinreb RN
        • Bowd C
        • Zangwill LM
        Scanning laser polarimetry in monkey eyes using variable corneal polarization compensation.
        J Glaucoma. 2002; 11: 378-384
        • Bagga H
        • Greenfield DS
        • Feuer W
        • Knighton RW
        Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
        Am J Ophthalmol. 2003; 135: 521-529
        • Choi J
        • Cho HS
        • Lee CH
        • Kook MS
        Scanning laser polarim-etry with variable corneal compensation in the area of apparently normal hemifield in eyes with normal-tension glaucoma.
        Ophthalmology. 2006; 113: 1954-1960
        • Reus NJ
        • Zhou Q
        • Lemij HG
        Enhanced imaging algorithm for scanning laser polarimetry with variable corneal compensation.
        Invest Ophthalmol Vis Sci. 2006; 47: 3870-3877
        • Bowd C
        • Medeiros FA
        • Weinreb RN
        • Zangwill LM
        The effect of atypical birefringence patterns on glaucoma detection using scanning laser polarimetry with variable corneal compensation.
        Invest Ophthalmol Vis Sci. 2007; 48: 223-227
        • Medeiros FA
        • Bowd C
        • Zangwill LM
        • Patel C
        • Weinreb RA
        Detection of glaucoma using scanning laser polarimetry with enhanced corneal compensation.
        Invest Ophthalmol Vis Sci. 2007; 48: 3146-3153
        • Sehi M
        • Ume S
        • Greenfield DS
        Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
        Invest Ophthalmol Vis Sci. 2007; 48: 2099-2104
        • Kwartz AJ
        • Henson DB
        • Harper RA
        • Spencer AF
        • McLeod D
        The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma.
        Health Technol Assess. 2005; 9 (iii): 1-132
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Sample PA
        • Weinreb RA
        Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma.
        Invest Ophthalmol Vis Sci. 2006; 47: 1008-1015
        • Shunmugam M
        • Azuara-Blanco A
        The quality of reporting of diagnostic accuracy studies in glaucoma using the Heidelberg retina tomograph.
        Invest Ophthalmol Vis Sci. 2006; 47: 2317-2323
        • Johnson ZK
        • Siddiqui MA
        • Azuara-Blanco A
        The quality of reporting of diagnostic accuracy studies of optical coherence tomography in glaucoma.
        Ophthalmology. 2007; 114: 1607-1612
        • Lin SC
        • Singh K
        • Jampel HD
        • et al.
        • Ophthalmic Technology Assessment Committee Glaucoma Panel
        Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1937-1949
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Weinreb RN
        Comparison of the GDx VCC scanning laser polarimeter, HRT II con-focal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma.
        Arch Ophthalmol. 2004; 122: 827-837
        • Deleón-Ortega JE
        • Arthur SN
        • McGwin Jr, G
        • Xie A
        • Monheit BE
        • Girkin CA
        Discrimination between glaucomatous and nonglaucomatous eyes using quantitative imaging devices and subjective optic nerve head assessment.
        Invest Ophthalmol Vis Sci. 2006; 47: 3374-3380
        • Greaney MJ
        • Hoffman DC
        • Garway-Heath DF
        • Nakla M
        • Cole-man A
        • Caprioli J
        Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma.
        Invest Ophthalmol Vis Sci. 2002; 43: 140-145
        • Reus NJ
        • de Graaf M
        • Lemij HG
        Accuracy of GDx VCC, HRT I, and clinical assessment of stereoscopic optic nerve head photographs for diagnosing glaucoma.
        Br J Ophthalmol. 2007; 91: 313-318
        • Kourkoutas D
        • Buys YM
        • Flanagan JG
        • Hatch WV
        • Balian C
        • et al.
        Comparison of glaucoma progression evaluated with Heidelberg retina tomograph II versus optic nerve head stereophotographs.
        Can J Ophthalmol. 2007; 42: 82-88
        • Kamal DS
        • Garway-Heath DF
        • Hitchings RA
        • Fitzke FW
        Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma.
        Br J Ophthalmol. 2000; 84: 993-998
        • Mohammadi K
        • Bowd C
        • Weinreb RN
        • Medeiros FA
        • Sample PA
        • Zangwill LM
        Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss.
        Am J Ophthalmol. 2004; 138: 592-601
        • Lalezary M
        • Medeiros FA
        • Weinreb RN
        • et al.
        Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.
        Am J Ophthalmol. 2006; 142: 576-582
        • Wolfs RC
        • Ramrattan RS
        • Hofman A
        • de Jong PT
        • et al.
        Cup-to-disc ratio: ophthalmoscopy versus automated measurement in a general population: The Rotterdam Study.
        Ophthalmology. 1999; 106: 1597-1601
        • Kamal DS
        • Viswanathan AC
        • Garway-Heath DF
        • Hitchings RA
        • Poinoosawmy D
        • Bunce C
        Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma.
        Br J Ophthalmol. 1999; 83: 290-294
        • Chauhan BC
        • McCormick TA
        • Nicolela MT
        • LeBlanc RP
        Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography.
        Arch Ophthalmol. 2001; 119: 1492-1499
        • Nicolela MT
        • McCormick TA
        • Drance SM
        • Ferrier SM
        • LeBlanc RP
        • Chauhan BC
        Visual field and optic disc progression in patients with different types of optic disc damage: a longitudinal prospective study.
        Ophthalmology. 2003; 110: 2178-2184
        • Wollstein G
        • Schuman JS
        • Price LL
        • et al.
        Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma.
        Arch Ophthalmol. 2005; 123: 464-470
        • Artes PH
        • Chauhan BC
        Longitudinal changes in the visual field and optic disc in glaucoma.
        Prog Retin Eye Res. 2005; 24: 333-354
        • Coleman AL
        • Sommer A
        • Enger C
        • Knopf HL
        • Stamper RL
        • Minckler DS
        Interobserver and intraobserver variability in the detection of glaucomatous progression of the optic disc.
        J Glaucoma. 1996; 5: 384-389
        • Ervin JC
        • Lemij HG
        • Mills RP
        • Quigley HA
        • Thompson HW
        • Burgoyne CF
        Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study.
        Ophthalmology. 2002; 109: 467-481
        • Azuara-Blanco A
        • Katz LJ
        • Spaeth GL
        • Vernon SA
        • Spencer F
        • Lanzl IM
        Clinical agreement among glaucoma experts in the detection of glaucomatous changes of the optic disk using simultaneous stereoscopic photographs.
        Am J Ophthalmol. 2003; 136: 949-950
        • Quigley HA
        • Addicks EM
        • Green WR
        • Maumenee AE
        Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.
        Arch Ophthalmol. 1981; 99: 635-649
        • Quigley HA
        • Dunkelberger GR
        • Green WR
        Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.
        Am J Ophthalmol. 1989; 107: 453-464
        • Bengtsson B
        • Heijl A
        Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma.
        Acta Ophthalmol Scand. 1998; 76: 268-272
        • Artes PH
        • Iwase A
        • Ohno Y
        • Kitazawa Y
        • Chauhan BC
        Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies.
        Invest Ophthalmol Vis Sci. 2002; 43: 2654-2659
        • Gonzales de la Rosa M
        • Morales J
        • Dannheim F
        • et al.
        Multicenter evaluation of tendency-oriented perimetry (TOP) using the G1 grid.
        Eur J Ophthalmol. 2003; 13: 32-41
        • Dacey DM
        • Lee BB
        The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type.
        Nature. 1994; 367: 731-735
        • Martin PR
        • White AJ
        • Goodchild AK
        • Wilder HD
        • Sefton AE
        Evidence that blue-on cells are part of the third geniculocortical pathway in primates.
        Eur J Neurosci. 1997; 9: 1536-1541
        • Johnson CA
        • Adams AJ
        • Casson EJ
        • Brandt JD
        Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
        Arch Ophthalmol. 1993; 111: 645-650
        • Girkin CA
        • Emdadi A
        • Sample PA
        • et al.
        Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping.
        Arch Ophthalmol. 2000; 118: 1231-1236
        • Johnson CA
        • Sample PA
        • Zangwill LM
        Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics.
        Am J Ophthalmol. 2003; 135: 148-154
        • Sample PA
        • Medeiros FA
        • Racette L
        • et al.
        Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study.
        Invest Ophthalmol Vis Sci. 2006; 47: 3381-3389
        • Shabana N
        • Cornilleau-Pérès V
        • Carkeet A
        • Chew PT
        Motion perception in glaucoma patients: a review.
        Surv Ophthalmol. 2003; 48: 92-106
        • Brusini P
        • Salvetat ML
        • Zeppieri M
        • Parisi L
        Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test.
        J Glaucoma. 2006; 15: 77-83
        • Girkin CA
        Relationship between structure of optic nerve/nerve fiber layer and functional measurements in glaucoma.
        Curr Opin Ophthalmol. 2004; 15: 96-101
        • Blumenthal EZ
        • Horani A
        • Sasikumar R
        • Garudadri C
        • Udaykumar A
        • Thomas R
        Correlating structure with function in end-stage glaucoma.
        Ophthalmic Surg Lasers Imaging. 2006; 37: 218-223
        • Heijl A
        • Bengtsson B
        • Chauhan BC
        • et al.
        A comparison of visual field progression criteria of 3 major glaucoma trials in Early Manifest Glaucoma Trial patients.
        Ophthalmology. 2008; Mar 29; ([Epub ahead of print])
        • Haymes SA
        • Hutchison DM
        • McCormick TA
        • et al.
        Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
        Invest Ophthalmol Vis Sci. 2005; 46: 547-554
        • Artes PH
        • Hutchison DM
        • Nicolela MT
        • LeBlanc RP
        • Chauhan BC
        Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
        Invest Ophthalmol Vis Sci. 2005; 46: 2451-2457
        • Zalta AH
        Use of a central 10 field and size V stimulus to evaluate and monitor small central islands of vision in end stage glaucoma.
        Br J Ophthalmol. 1991; 75: 151-154
        • Ahmed II
        • Feldman F
        • Kucharczyk W
        • et al.
        Neuroradiologic screening in normal-pressure glaucoma: study results and literature review.
        J Glaucoma. 2002; 11: 279-286
        • O’Brien C
        • Saxton V
        • Crick RP
        • Meire H
        Doppler carotid artery studies in asymmetric glaucoma.
        Eye. 1992; 6: 273-276
        • Leske MC
        • Heijl A
        • Hyman L
        • Bengtsson B
        • Dong L
        • Yang Z
        • EMGT Group
        Predictors of long-term progression in the early manifest glaucoma trial.
        Ophthalmology. 2007; 114: 1965-1972
        • Graham SL
        • Drance SM
        • Wijsman K
        • Douglas GR
        • Mikelberg FS
        Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.
        Ophthalmology. 1995; 102: 61-69
        • Hayreh SS
        • Zimmerman MB
        • Podhjasky P
        • Alward WL
        Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.
        Am J Ophthalmol. 1994; 117: 603-624
        • Klein BE
        • Klein R
        • Sponsel WE
        • et al.
        Prevalence of glaucoma. The Beaver Dam Eye Study.
        Ophthalmology. 1992; 99: 1499-1504
        • Shiose Y
        • Kitazaøwa Y
        • Tsukahara S
        • et al.
        Epidemiology of glaucoma in Japan—a nationwide glaucoma survey.
        Jpn J Ophthalmol. 1991; 35: 133-155
        • Anderson DR
        • Drance SM
        • Schulzer M
        • Collaborative Normal-Tension Glaucoma Study Group
        Natural history of normal-tension glaucoma.
        Ophthalmology. 2001; 108: 247-253
        • Campbell DG
        Pigmentary dispersion and glaucoma. A new theory.
        Arch Ophthalmol. 1979; 97: 1667-1672
        • Greenstein VC
        • Seiple W
        • Liebmann J
        • Ritch R
        Retinal pigment epithelial dysfunction in patients with pigment dispersion syndrome: implications for the theory of pathogenesis.
        Arch Ophthalmol. 2001; 119: 1291-1295
        • Karichoff JR
        Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique.
        Ophthalmic Surg. 1992; 23: 269-277
        • Kanadani FN
        • Dorairaj S
        • Langlieb AM
        • et al.
        Ultrasound biomicroscopy in asymmetric pigment dispersion syndrome and pigmentary glaucoma.
        Arch Ophthalmol. 2006; 124: 1573-1576
        • Lord FD
        • Pathanapitoon K
        • Mikelberg FS
        Keratometry and axial length in pigment dispersion syndrome: a descriptive case-control study.
        J Glaucoma. 2001; 10: 383-385
        • Breingan PJ
        • Esaki K
        • Ishikawa H
        • Liebmann JM
        • Greenfield DS
        • Ritch R
        Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome.
        Arch Ophthalmol. 1999; 117: 325-328
        • Kuchle M
        • Nguyen NX
        • Mardin CY
        • Naumann GO
        Effect of neodymium: YAG laser iridotomy on number of aqueous melanin granules in primary pigment dispersion syndrome.
        Graefes Arch Clin Exp Ophthalmol. 2001; 239: 411-415
        • Reistsad CE
        • Shields MD
        • Campbell DG
        • Ritch R
        • Wang JC
        • Wand M
        The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma.
        J Glaucoma. 2005; 14: 255-259
        • Glaucoma Laser Trial Group I
        Acute effects of argon laser trabeculoplasty on intraocular pressure. Glaucoma Laser Trial Research Group.
        Arch Ophthalmol. 1989; 107: 1135
        • Gandolfi SA
        • Vecchi M
        Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome.
        Ophthalmology. 1996; 103: 1693-1695
        • Ritch R
        Exfoliation syndrome and occludable angles.
        Trans Am Ophthalmol Soc. 1994; 92: 845-944
        • Konstas AG
        • Stewart WC
        • Stroman GA
        • Sine CS
        Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma.
        Ophthalmic Surg Lasers. 1997; 28: 111-117
        • Ritch R
        • Schlötzer-Schrehardt U
        • Konstas AG
        Why is glaucoma associated with exfoliation syndrome?.
        Prog Retin Eye Res. 2003; 22: 253-275
        • Schlotzer-Schrehardt UM
        • Koca MR
        • Naumann GO
        • Volkhlotz H
        Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?.
        Arch Ophthalmol. 1992; 110: 1752-1756
        • Conway RM
        • Schlötzer-Schrehardt U
        • Küchle M
        • Naumann GO
        Pseudoexfoliation syndrome: pathological manifestations of relevance to intraocular surgery.
        Clin Experiment Ophthalmol. 2004; 32: 199-210
        • Konstas AG
        • Tsironi S
        • Ritch R
        Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.
        Compr Ophthalmol Update. 2006; 7: 131-141
        • Layden WE
        • Shaffer RN
        Pseudoexfoliation syndrome.
        Am J Ophthalmol. 1974; 78: 835
        • Naumann GO
        • Schlotzer-Schrehardt Yu
        • Kuchle M
        Pseudo-exfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.
        Ophthalmology. 1998; 105: 951-968
        • Shuba L
        • Nicolela MT
        • Rafuse PE
        Correlation of capsular pseudoexfoliation material and iridocorneal angle pigment with the severity of pseudoexfoliation glaucoma.
        J Glaucoma. 2007; 16: 94-97
        • Repo LP
        • Suhonen MT
        • Teräsvirta ME
        • Koivisto KJ
        Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome.
        Ophthalmology. 1995; 102: 1199-1205
        • Mitchell P
        • Wang JJ
        • Smith W
        Association of pseudoexfoliation syndrome with increased vascular risk.
        Am J Ophthalmol. 1997; 124: 685-687
        • Citirik M
        • Acaroglu G
        • Batman C
        • Yildiran L
        • Zilelioglu O
        A possible link between the pseudoexfoliation syndrome and coronary artery disease.
        Eye. 2007; 21: 11-15
        • Ritland JS
        • Egge K
        • Lydersen S
        • et al.
        Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
        Acta Ophthalmol Scand. 2004; 82: 401-404
        • Thorleifsson G
        • Magnusson KP
        • Sulem P
        • et al.
        Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
        Science. 2007; 317: 1397-1400
        • Liu X
        • Zhao Y
        • Gao J
        • Pawlyk B
        • Starcher B
        • Spencer JA
        • Yan-agisawa H
        • Zuo J
        • Li T
        Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.
        Nat Genet. 2004; 36: 178-182
        • Konstas AG
        • Tsatsos I
        • Kardasopoulos A
        • Bufidis T
        • Maskaleris G
        Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study.
        Acta Ophthalmol Scand. 1998; 76: 208-212
        • Konstas AG
        • Mylopoulos N
        • Karabatsas CH
        • et al.
        Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
        Eye. 2004; 18: 893-899
        • Konstas AG
        • Hollo G
        • Astakhov YS
        • et al.
        Factors associated with long-term progression or stability in exfoliation glaucoma.
        Arch Ophthalmol. 2004; 122: 29-33
        • Congdon NG
        • Quigley HA
        • Hung PT
        • et al.
        Screening techniques for angle closure glaucoma in rural Taiwan.
        Acta Ophthalmol Scand. 1996; 74: 113-119
        • Foster PJ
        • Baasanhu J
        • Alsbirk PH
        • et al.
        Glaucoma in Mongolia. A population based survey in Hovsgol province, northern Mongolia.
        Arch Ophthalmol. 1996; 114: 1235-1241
        • Sim DH
        • Goh LG
        • Ho T
        Glaucoma pattern amongst the elderly Chinese in Singapore.
        Ann Acad Med Singapore. 1998; 27: 819-823
        • Dandona L
        • Dandona R
        • Mandal P
        • et al.
        Angle closure glaucoma in an urban population in southern India.
        Ophthalmology. 2000; 107: 1710-1716
        • Vijaya L
        • George R
        • Arvind H
        • et al.
        Prevalence of angle closure disease in a rural southern Indian Population.
        Arch Ophthalmol. 2006; 124: 403-409
        • Casson RJ
        • Newland HS
        • Muecke J
        • et al.
        Goniscopy findings and prevalence of occludable angles in a Burmese population: the Meiktila Eye Study.
        Br J Ophthalmol. 2007; 91: 856-859
        • Aung T
        • Nolan WP
        • Machin D
        • et al.
        Anterior chamber depth and the risk of primary angle closure in 2 East Indian populations.
        Arch Ophthalmol. 2005; 123: 527-532
        • Foster PJ
        • Oen FTS
        • Machin D
        • et al.
        The prevalence of glaucoma in Chinese residents of Singapore.
        Arch Ophthalmol. 2000; 118: 1105-1111
        • Seah SKL
        • Foster PJ
        • Chew PTK
        • et al.
        Indidence of acute primary angle closure glaucoma in Singapore.
        Arch Ophthalmol. 1997; 115: 1436-1440
        • Arkell SM
        • Lightman DA
        • Sommer A
        • et al.
        The prevalence of glaucoma among Eskimos of northwest Alaska.
        Arch Ophthal-mol. 1987; 105: 482-485
        • Bourne RR
        • Sorensen KE
        • Klauber A
        • et al.
        Glaucoma in East Greenlandic Inuit-a population survey in Ittoqqortoormit.
        Acta Ophthalmol Scand. 2001; 79: 462-467
        • Van Rens GH
        • Arkell SM
        • Charlton W
        • Doesburg W
        Primary angle closure glaucoma among Alaskan Eskimos.
        Doc Ophthalmol. 1988; 70: 265-276
        • Lowe RF
        Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma.
        Br J Ophthalmol. 1970; 54: 1619
        • Spaeth GL
        Gonioscopy: uses old and new-the inheritance of occludable angles.
        Ophthalmology. 1978; 85: 222-232
        • Markowitz SN
        • Morin JD
        Angle-closure glaucoma relation between lens thickness, anterior chamber depth and age.
        Can J Ophthalmol. 1984; 19: 300-302
        • Amerasinghe N
        • Aung T
        Angle-closure: risk factors, diagnosis and treatment.
        Prog Brain Res. 2008; 173: 31-35
        • Drance SM
        Angle closure glaucoma among Canadian Eskimos.
        Can J Ophthalmol. 1973; 8: 252-254
        • Van Herick W
        • Shaffer RN
        • Schwartz A
        Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle.
        Am J Ophthalmol. 1969; 68: 626-629
        • Lavanya R
        • Wong TY
        • Friedman DS
        • Aung HT
        • Alfred T
        • Gao H
        • Seah SK
        • et al.
        Determinants of angle closure in older singaporeans.
        Arch Ophthalmol. 2008; 126: 686-691
        • Anderson DR
        Corneal indentation to relieve acute angle-closure glaucoma.
        Am J Ophthalmol. 1979; 88: 1091-1093
        • Lai JSM
        • Tham CCY
        • Chua JKH
        • et al.
        Laser peripheral irido-plasty as initial treatment of acute attack of primary angle closure: A long term follow up study.
        J Glaucoma. 2002; 11: 484-487
        • Lam DSC
        • Lai JSM
        • Tham CCY
        • et al.
        Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle closure glaucoma.
        Ophthalmology. 2002; 109: 1591-1596
        • Lam DSC
        • Chua JKH
        • Tham CCT
        • et al.
        Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle closure glaucoma.
        Ophthalmology. 2002; 109: 64-70
        • Greve EL
        Primary angle closure glaucoma: extracapsular extraction or filtering procedure?.
        Int Ophthalmol. 1988; 12: 157-162
        • Schwartz GF
        • Steinmann WC
        • Spaeth GL
        • Wilson RP
        Surgical and medical management of patients with narrow anterior chamber angles: comparative results.
        Ophthalmic Surg. 1992; 23: 108-112
      9. Ang LP, Aung T, Chew PT. Acute primary angle closure in an Asian population. Long term outcome of the fellow eye after prophylactic laser peripheral iridotomy. Ophthalmology 200;107:2092–6.

        • Friedman DS
        • Chew PTK
        • Gazzard G
        • et al.
        Long term outcomes in fellow eyes after acute primary angle closure in the contralateral eye.
        Ophthalmology. 2006; 113: 1087-1091
        • Saw SM
        • Gazzard DS
        • Friedman
        Interventions for angle closure glaucoma. An evidence based update.
        Ophthalmology. 2003; 110: 1869-1879
        • Iliev ME
        • Gerber S
        Long-term Outcome of trans-scleral laser cyclophotocoagulation in refractory glaucoma.
        Br J Ophthalmol. 2007; 91: 1631-1635
        • Chandler PA
        • Simmons RS
        • Grant WM
        Malignant glaucoma. Medical and surgical treatment.
        Am J Ophthalmol. 1968; 66: 2495-2502
        • Epstein DL
        • Steinert RF
        • Puliafito CA
        Neodymium-YAG laser therapy to the anterior hyaloid in aphakic malignant (ciliovitreal block) glaucoma.
        Am J Ophthalmol. 1984; 98: 137-143
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study Group
        The European glaucoma prevention study design and baseline description of the participants.
        Ophthalmology. 2002; 109: 1612-1621
        • Graham SL
        • Drance SM
        • Chauhan BC
        • et al.
        Comparison of psychophysical and electrophysiological testing in glaucoma.
        Invest Ophthalmol Vis Sci. 1996; 37: 2651-2662
        • Chauhan BC
        • Garway-Heath DF
        • Goni FJ
        • et al.
        Practical recommendations for measuring rates of visual field change in glaucoma.
        Br J Ophthalmol. 2008; 92: 569-573
        • AGIS Investigators
        • Advanced Glaucoma Intervention Study (AGIS)
        1. Study design and methods and baseline characteristics of study patients.
        Control Clin Trials. 1994; 15: 299-325
        • Musch DC
        • Lichter PR
        • Guire KE
        • Standardi CL
        The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.
        Ophthalmology. 1999; 106: 653-662
        • Heijl A
        • Leske MC
        • Bengtsson B
        • Bengtsson B
        • Hussein M
        • Early Manifest Glaucoma Trial Group
        Measuring visual field progression in the Early Manifest Glaucoma Trial.
        Acta Ophthalmol Scand. 2003; 81: 286-293
        • Drance SM
        Disc hemorrhages in the glaucomas.
        Surv Ophthal-mol. 1989; 33: 331-337
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study Group
        The European glaucoma prevention study design and baseline description of the participants.
        Ophthalmology. 2002; 109: 1612-1621
        • AGIS Investigators
        • The Advanced Glaucoma Intervention Study (AGIS)
        12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.
        Am J Ophthalmol. 2002; 134: 499-512
        • Caprioli J
        • Coleman AL
        Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressure in the advanced glaucoma intervention study.
        Ophthalmology. 2008; 115: 1123-1129
        • Noe G
        • Ferraro J
        • Lamoureux E
        • Rait J
        • Keeffe JE
        Associations between glaucomatous visual field loss and participation in activities of daily living.
        Clin Experiment Ophthalmol. 2003; 31: 482-486
        • Altangerel U
        • Spaeth GL
        • Rhee DJ
        Visual function, disability, and psychological impact of glaucoma.
        Curr Opin Ophthalmol. 2003; 14: 100-105
        • Janz NK
        • Wren PA
        • Lichter PR
        • Musch DC
        • Gillespie BW
        • Guire KE
        Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study.
        Ophthalmology. 2001; 108: 887-897
        • Haymes SA
        • Leblanc RP
        • Nicolela MT
        • Chiasson LA
        • Chauhan BC
        Risk of falls and motor vehicle collisions in glaucoma.
        Invest Ophthalmol Vis Sci. 2007; 48: 1149-1155
        • Sherwood MB
        • Garcia-Siekavizza A
        • Meltzer MI
        • Hebert A
        • Burns AF
        • McGorray S
        Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study.
        Ophthalmology. 1998; 105: 561-566
        • Nelson P
        • Aspinall P
        • Papasouliotis O
        • Worton B
        • O’Brien C
        Quality of life in glaucoma and its relationship with visual function.
        Glaucoma. 2003; 12: 139-150
        • Kobelt G
        • Jonsson B
        • Bergström A
        • Chen E
        • Lindén C
        • Alm A
        Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
        Acta Ophthalmol Scand. 2006; 84: 363-371
        • Parrish 2nd, RK
        • Gedde SJ
        • Scott IU
        • Feuer WJ
        • Schiffman JC
        • Mangione CM
        • Montenegro-Piniella A
        Visual function and quality of life among patients with glaucoma.
        Arch Ophthalmol. 1997; 115: 1447-1455
        • Hyman LG
        • Komaroff E
        • Heijl A
        • Bengtsson B
        • Leske MC
        • Early Manifest Glaucoma Trial Group
        Treatment and vision-related quality of life in the early manifest glaucoma trial.
        Ophthalmology. 2005; 112: 505-513
        • Gupta V
        • Srinivasan G
        • Mei SS
        • Gazzard G
        • Sihota R
        • Kapoor KS
        Utility values among glaucoma patients: an impact on the quality of life.
        Br J Ophthalmol. 2005; 89: 1241-1244
        • Blondeau P
        • Esper P
        • Mazerolle E
        An information session for glaucoma patients.
        Can J Ophthalmol. 2007; 42: 816-820
        • Asrani S
        • Zeiner R
        • Wilensky J
        • Gieser D
        • Vitale S
        • Lindenmuth K
        Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.
        J Glaucoma. 2000; 9: 134-142
        • Stewart WC
        • Feldman R
        • Mychaskiw MA
        Ocular blood flow in glaucoma: the need for further clinical evidence and patient outcomes research.
        Br J Ophthalmol. 2007; 91: 1263-1264
        • Weinreb RN
        Glaucoma neuroprotection: What is it? Why is it needed?.
        Can J Ophthalmol. 2007; 42: 396-398
        • Borras T
        • Brandt CR
        • Nickells R
        • Ritch R
        Gene therapy for glaucoma: treating a multifaceted, chronic disease.
        Invest Ophthalmol Vis Sci. 2002; 43: 2513-2518
        • Japan Glaucoma Society
        The Japan Glaucoma Society Guidelines for Glaucoma. Japan Glaucoma Society, Tokyo2002 ([English translation, April 2004] Available at:) (Accessed July 8, 2008)
        • American Academy of Ophthalmology
        Primary Open-Angle Glaucoma. Preferred Practice Pattern. American Academy of Ophthalmology, San Francisco, CA2005 (Available at:) (Accessed July 8, 2008)
        • Hodapp E
        • Parrish RP
        • Anderson D
        Clinical Decisions in Glaucoma. CV Mosby Company, St. Louis, Mo.1993: 65
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study (EGPS) Group
        Results of the European Glaucoma Prevention Study.
        Ophthalmology. 2005; 112: 366-375
        • Feiner L
        • Piltz-Seymour JR
        • Collaborative Initial Glaucoma Treatment Study
        Collaborative Initial Glaucoma Treatment Study: a summary of results to date.
        Curr Opin Ophthalmol. 2003; 14: 106-111
        • Odberg T
        Visual field prognosis in advanced glaucoma.
        Acta Ophthalmol. 1987; 65: 27-29
        • Lachaine J
        • Hodge WG
        • Steffensen I
        • Murray C
        • Barnes D
        • Foerster V
        • et al.
        Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysis.
        Can J Ophthalmol. 2008; 43: 33-41
        • Vass C
        • Hirn C
        • Sycha T
        • Findl O
        • Sacu S
        • Bauer P
        • Schmetterer L
        Medical interventions for primary open angle glaucoma and ocular hypertension.
        Cochrane Database Syst Rev. 2007; 4: CD003167
        • Zhang WY
        • Po AL
        • Dua HS
        • Azuara-Blanco A
        Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
        Br J Ophthalmol. 2001; 85: 983-990
        • Fechtner RD
        • Realini T
        Fixed combinations of topical glaucoma medications.
        Curr Opin Ophthalmol. 2004; 15: 132-135
        • Realini T
        • Fechtner RD
        • Atreides SP
        • Gollance S
        The uniocular drug trial and second-eye response to glaucoma medications.
        Ophthalmology. 2004; 111: 421-426
        • Sit AJ
        • Liu JH
        • Weinreb RN
        Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients.
        Ophthalmology. 2006; 113: 425-430
        • Quigley HA
        • Friedman DS
        • Hahn SR
        Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
        Ophthalmology. 2007; 114: 1599-1606
        • Olthoff CM
        • Schouten JS
        • van de Borne BW
        • Webers CA
        Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.
        Ophthalmology. 2005; 112: 953-961
        • Zhou Z
        • Althin R
        • Sforzolini BS
        • Dhawan R
        Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.
        Br J Ophthalmol. 2004; 88: 1391-1394
        • Sleath B
        • Robin AL
        • Covert D
        • Byrd JE
        • Tudor G
        • Svarstad B
        Patient-reported behavior and problems in using glaucoma medications.
        Ophthalmology. 2006; 113: 431-436
        • Patel SC
        • Spaeth GL
        Compliance in patients prescribed eye drops for glaucoma.
        Ophthalmic Surg. 1995; 26: 233-236
        • Englert JA
        • Cox TA
        • Allingham RR
        • Shields MB
        Argon vs diode laser trabeculoplasty.
        Am J Ophthalmol. 1997; 124: 627-631
        • Glaucoma Laser Trial Research Group
        Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up Study: 7. Results.
        Am J Ophthalmol. 1995; 120: 718-731
        • Spaeth GL
        • Baez KA
        Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years.
        Arch Ophthalmol. 1992; 110: 491-494
        • Schwartz AL
        • Love DC
        • Schwartz MA
        Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma.
        Arch Ophthalmol. 1985; 103: 1482-1484
        • Krupin T
        • Patkin R
        • Kurata FK
        • Bishop KI
        • Keates EU
        • Kozart DM
        • et al.
        Argon laser trabeculoplasty in black and white patients with primary open-angle glaucoma.
        Ophthalmology. 1986; 93: 811-816
        • Shingleton BJ
        • Richter CU
        • Dharma SK
        • et al.
        Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study.
        Ophthalmology. 1993; 100: 1324-1329
        • Damji KF
        • Bovell AM
        • Hodge WG
        • Rock W
        • Shah K
        • Buhrmann R
        • Pan YI
        Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial.
        Br J Ophthalmol. 2006; 90: 1490-1494
        • Nagar M
        • Ogunyomade A
        • O’Brart DP
        • Howes F
        • Marshall J
        A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
        Br J Ophthalmol. 2005; 89: 1413-1417
        • Ren J
        • Shin DH
        • Chung HS
        • Birt CM
        • Glover BK
        • Juzych MS
        • et al.
        Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
        Ophthalmology. 1999; 106: 1135-1139
        • Ma YR
        • Lee BH
        • Yang KJ
        • Park YG
        The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty.
        Korean J Ophthalmol. 1999; 13: 78-84
        • Elsås T
        • Johnsen H
        • Brevik TA
        The immediate pressure response to primary laser trabeculoplasty—a comparison of one-and two-stage treatment.
        Acta Ophthalmol. 1989; 67: 664-668
        • Rachmiel R
        • Trope GE
        • Chipman ML
        • Gouws P
        • Buys YM
        Effect of medical therapy on glaucoma filtration surgery rates in Ontario.
        Arch Ophthalmol. 2006; 124: 1472-1477
        • AGIS Investigators
        Advanced Glaucoma Intervention Study (AGIS); 13. Comparison of treatment outcomes within race: 10-year results.
        Ophthalmology. 2004; 111: 651-664
        • Araujo SV
        • Spaeth GL
        • Roth SM
        • Starita RJ
        A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy.
        Ophthalmology. 1995; 102: 1753-1759
        • Fluorouracil Filtering Surgery Study Group
        Fluorouracil Filtering Surgery Study one-year follow-up.
        Am J Ophthalmol. 1989; 108: 625-635
        • Wormald R
        • Wilkins MR
        • Bunce C
        Postoperative 5-Fluorouracil for glaucoma surgery.
        Cochrane Database Syst Rev. 2001; 1: CD001132
        • Wilkins M
        • Indar A
        • Wormald R
        Intraoperative mitomycin C for glaucoma surgery.
        Cochrane Database Syst Rev. 2005; 4: CD002897
        • Costa VP
        • Wilson RP
        • Moster MR
        • et al.
        Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery.
        Ophthalmic Surg. 1993; 24: 389-394
        • Zacharia PT
        • Deppermann SR
        • Schuman JS
        Ocular hypotony after trabeculectomy with mitomycin C.
        Am J Ophthalmol. 1993; 116: 314-326
        • Greenfield DS
        • Liebmann JM
        • Jee J
        • Ritch R
        Late-onset bleb leaks after glaucoma filtering surgery.
        Arch Ophthalmol. 1998; 116: 443-447
        • Soltau JB
        • Rothman RF
        • Budenz DL
        • et al.
        Risk factors for glaucoma filtering bleb infections.
        Arch Ophthalmol. 2000; 118: 338-342
        • Jampel HD
        • Quigley HA
        • Kerrigan-Baumrind LA
        • Meila BM
        • Friedman D
        • Barron Y
        • Glaucoma Surgical Outcomes Study Group
        Risk factors for late-onset infection following glaucoma filtration surgery.
        Arch Ophthalmol. 2001; 119: 1001-1008
        • Whiteside-Michel J
        • Liebmann JM
        • Ritch R
        Initial 5-fluorouracil trabeculectomy in young patients.
        Ophthalmology. 1992; 99: 7-13
        • Suñer IJ
        • Greenfield DS
        • Miller MP
        • Nicolela MT
        • Palmberg PF
        Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment.
        Ophthalmology. 1997; 104: 207-214
        • Yarangümeli A
        • Güreser S
        • Köz OG
        • Elhan AH
        • Kural G
        Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma.
        Int Ophthalmol. 2004; 25: 207-213
        • Yalvac IS
        • Sahin M
        • Eksioglu U
        • Midillioglu IK
        • Aslan BS
        • Duman S
        Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomized clinical trial.
        J Cataract Refract Surg. 2004; 30: 2050-2057
        • Lüke C
        • Dietlein TS
        • Jacobi PC
        • Konen W
        • Krieglstein GK
        A prospective randomized trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study.
        J Glaucoma. 2002; 11: 294-299
        • Kobayashi H
        • Kobayashi K
        • Okinami S
        A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.
        Graefes Arch Clin Exp Ophthalmol. 2003; 241: 359-366
        • Carassa RG
        • Bettin P
        • Fiori M
        • Brancato R
        Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial.
        Ophthalmology. 2003; 110: 882-887
        • El Sayyad F
        • Helal M
        • El-Kholify H
        • Khalil M
        • El-Maghraby A
        Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma.
        Ophthalmology. 2000; 107: 1671-1674
        • Jonescu-Cuypers C
        • Jacobi P
        • Konen W
        • Krieglstein G
        Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: A randomized clinical trial.
        Ophthalmology. 2001; 108: 254-258
        • Netland PA
        • Ophthalmic Technology Assessment Committee Glaucoma Panel
        American Academy of Ophthalmology. Nonpenetrating glaucoma surgery.
        Ophthalmology. 2001; 108: 416-421
        • Hong CH
        • Arosemena A
        • Zurakowski D
        • Ayyala RS
        Glaucoma drainage devices: a systematic literature review and current controversies.
        Surv Ophthalmol. 2005; 50: 48-60
        • Minckler DS
        • Vedula SS
        • Li TJ
        • Mathew MC
        • Ayyala RS
        • Francis BA
        Aqueous shunts for glaucoma.
        Cochrane Database Syst Rev. 2006; 2: CD004918
        • Gedde SG
        • Schiffman JC
        • Feuer WJ
        • Herndon LW
        • Brandt JD
        • Budenz DL
        Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
        Am J Ophthalmol. 2007; 143: 9-22
        • Pastor SA
        • Singh K
        • Lee DA
        • et al.
        Cyclophotocoagulation: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2001; 108: 2130-2138
        • AGIS Investigators
        The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy.
        Arch Ophthalmol. 2001; 119: 1771-1780
        • Lichter PR
        • Müsch DC
        • Gillespie BW
        • et al.
        • CIGTS Study Group
        Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.
        Ophthalmology. 2001; 108: 1943-1953
        • Canadian Ophthalmological Society Cataract Surgery Clinical Practice Guideline Expert Committee
        Canadian Ophthalmo-logical Society evidence-based clinical practice guidelines for cataract surgery in the adult eye.
        Can J Ophthalmol. 2008; 43: S1-S34
        • Friedman DS
        • Jampel HD
        • Lubomski LH
        • Kempen JH
        • Quigley H
        • Congdon N
        • Levkovitch-Verbin H
        • Robinson KA
        • Bass EB
        Surgical strategies for coexisting glaucoma and cataract. An evidence-based update.
        Ophthalmology. 2002; 109: 1902-1915
        • Hayashi K
        • Hayashi H
        • Nakao F
        • Hayashi F
        Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma.
        Ophthalmology. 2000; 107: 698-703
        • Shingleton BJ
        • Heltzer J
        • O’Donoghue MW
        Outcomes of phacoemulsification in patients with and without Pseudoexfoliation syndrome.
        J Cataract Refract Surg. 2003; 29: 1080-1086
        • Damji KF
        • Konstas AG
        • Liebmann JM
        • et al.
        Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study.
        Br J Ophthalmol. 2006; 90: 1014-1018
        • Willoughby CE
        • Wishart PK
        Lensectomy in the management of glaucoma in spherophakia.
        J Cataract Refract Surg. 2002; 28: 1061-1064
        • Heltzer JM
        Coexisting glaucoma and cataract [comment].
        Ophthalmology. 2004; 111: 408-409
        • Hayashi K
        • Hayashi H
        • Nakao F
        • Hayashi F
        Effect of cataract surgery on intraocular pressure control in glaucoma patients.
        J Cataract Refract Surg. 2001; 27: 1779-1786
        • Crichton AC
        • Kirker AW
        Intraocular pressure and medication control after clear corneal phacoemulsification and AcrySof posterior chamber intraocular lens implantation in patients with filtering blebs.
        J Glaucoma. 2001; 10: 38-64
        • Casson R
        • Rahman R
        • Salmon JF
        Phacoemulsification with intraocular lens implantation after trabeculectomy.
        J Glaucoma. 2002; 11: 429-433
        • Mandai AK
        • Chelerkar V
        • Jain SS
        • et al.
        Outcome of cataract extraction and posterior chamber intraocular lens implantation following glaucoma filtration surgery.
        Eye. 2005; 19: 1000-1008
        • Rossetti L
        • Bucci L
        • Miglior S
        • Orzalesi N
        Temporal corneal phacoemulsification combined with separate-incision superior trabeculectomy vs standard phacotrabeculectomy. A comparative study.
        Acta Ophthalmol Scand Suppl. 1997; 224: 39
        • Peräsalo R
        • Flink T
        • Lehtosalo J
        • Ralli R
        • Sulonen J
        Surgical outcome of phaco-emulsification combined with trabeculectomy in 243 eyes.
        Acta Ophthalmol Scand. 1997; 75: 581-583
        • Wyse T
        • Meyer M
        • Ruderman JM
        • Krupin T
        • Talluto D
        • Hernandez R
        • Rosenberg LF
        Combined trabeculectomy and phacoemulsification: A one-site vs a two-site approach.
        Am J Ophthalmol. 1998; 125: 334-339
        • Bellucci R
        • Luraschi M
        Trabeculectomy and phacoemulsification: one-way and two-way approach compared after one year.
        Acta Ophthalmol Scand Suppl. 1998; 227: 50-51
        • Borggrefe J
        • Lieb W
        • Grehn F
        A prospective randomized comparison of two techniques of combined cataract-glaucoma surgery.
        Graefes Arch Clin Exp Ophthalmol. 1999; 237: 887-892
        • El Sayyad F
        • Helal M
        • El-Maghraby A
        • Khalil M
        • El-Hamzawey H
        One-site versus 2-site phacotrabeculectomy: A randomized study.
        J Cataract Refract Surg. 1999; 25: 77-82
        • Shingleton BJ
        • Price RS
        • O’Donoghue MW
        • Goyal S
        Comparison of 1-site versus 2-site phacotrabeculectomy.
        J Cataract Refract Surg. 2006; 32: 799-802
      10. Cotran PR, Roh S, McGwin G. Randomized comparison of 1-site and 2-site phacotrabeculectomy with 3-year follow-up. Ophthalmology; 115:44754.

        • Buys YM
        • Chipman ML
        • Zack B
        • Rootman DS
        • Slomovick AR
        • Trope GE
        Prospective randomized comparison of one- versus two-site phacotrabeculectomy: two-year results.
        Ophthalmology. 2008; 115: 1130-1133
        • Jampel HD
        • Friedman DS
        • Lubomski LH
        • et al.
        Effect of technique on intraocular pressure after combined cataract and glaucoma surgery. An evidence-based review.
        Ophthalmology. 2002; 109: 2215-2224
        • Casson RJ
        • Salmon JF
        Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
        J Cataract Refract Surg. 2001; 27: 1854-1863
        • Hopkins JJ
        • Apel A
        • Trope GE
        • Rootman DS
        Early intraocular pressure after phacoemulsification combined with trabeculectomy.
        Ophthalmic Surg Lasers. 1998; 29: 273-279
        • Lemon LC
        • Shin DH
        • Kim C
        • Bendel RE
        • Hughes BA
        • Juzych MS
        Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
        Am J Ophthalmol. 1998; 125: 340-345
        • Shingleton BJ
        • Chaudhry IM
        • O’Donoghue MW
        • Baylus SL
        • King RJ
        • Chaudry MB
        Phacotrabeculectomy: limbus-based versus fornix-based conjuinctival flaps in fellow eyes.
        Ophthalmology. 1999; 106: 1152-1155
        • Kozobolis VP
        • Siganos CS
        • Christodoulakis EV
        • Lazarow NP
        • Koutentaki MG
        • Pallikaris IG
        Two-site phacotrabeculectomy with intraoperative mitomycin C: fornix- versus limbus-based conjunctival opening in fellow eyes.
        J Cataract Refract Surg. 2002; 28: 1758-1762